Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Tilly W. Hulscher"'
Autor:
E. H. Stet, Frank J.M. Damen, Marinka A.H. Bakker, John A. Van Baal, Jos P.M. Bökkerink, Tilly W. Hulscher, Ronney A. De Abreu
Publikováno v:
Biochemical Pharmacology. 45:1455-1463
The effects of prolonged exposure to 2 and 10 μM 6-mercaptopurine (6MP) in the human lymphoblastic T-cell line MOLT-4 were studied with respect to cell-kinetic parameters, phosphoribosyi pyrophosphate (PRPP) and purine ribonucleotide levels, formati
Autor:
Jos P.M. Bökkerink, Tilly W. Hulscher, John M. van Baal, Ronney A. De Abreu, E. D. A. M. Schretlen, Chris H. M. M. de Bruijn, Marinka A.H. Bakker
Publikováno v:
Purine and Pyrimidine Metabolism in Man V ISBN: 9781468412505
Methotrexate (MTX) and 6-mercaptopurine (6MP) are among the most commonly used agents in the maintenance treatment of acute lymphoblastic leukemia (ALL) in children.1-3 There are biochemical considerations for an increased efficacy of a combination o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd97e8c597cf4ce043a3e7bc2a8d4507
https://doi.org/10.1007/978-1-4684-1248-2_17
https://doi.org/10.1007/978-1-4684-1248-2_17
Autor:
Tilly W. Hulscher, Gerard A. M. de Vaan, Ronney A. De Abreu, E. D. A. M. Schretlen, Marinka A.H. Bakker, Jos P.M. Bökkerink, Chris H. M. M. de Bruijn
Publikováno v:
Purine and Pyrimidine Metabolism in Man V ISBN: 9781468412505
Methotrexate (MTX) is a well known inhibitor of purine de novo synthesis and thymidylate synthesis. In cells with an active purine de novo synthesis 5-phosphoribosyl-1-pyrophosphate (PRPP) levels are increased significantly, when the cells are expose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c4acd449ddacf6a321af096366d5743
https://doi.org/10.1007/978-1-4684-1248-2_20
https://doi.org/10.1007/978-1-4684-1248-2_20
Autor:
Jos P.M. Bökkerink, Ronney A. De Abreu, Chris H. M. M. de Bruijn, Tilly W. Hulscher, Marinka A.H. Bakker, E. D. A. M. Schretlen, Jan P R M Van Laarhoven
Publikováno v:
Purine and Pyrimidine Metabolism in Man V ISBN: 9781468412505
In response to inhibition of purine de novo biosynthesis by methotrexate (MTX), an increase in the availability of 5-phosphoribosyl-1-pyrophosphate (PRPP) occurs. As a result of this increased availability of PRPP, potentiation of 6-mercaptopurine (6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb58d90e2a2890063d5c1efc59840f02
https://doi.org/10.1007/978-1-4684-1248-2_21
https://doi.org/10.1007/978-1-4684-1248-2_21
Autor:
Tilly W. Hulscher, E. D. A. M. Schretlen, Marinka A.H. Bakker, Ronney A. De Abreu, Jos P.M. Bökkerink
Publikováno v:
Biochemical pharmacology. 37(12)
Methotrexate (MTX) causes an inhibition of purine de novo synthesis (PDNS), resulting in increased intracellular availability of 5-phosphoribosyl-1-pyrophosphate (PRPP) in human malignant lymphoblasts with an active PDNS. Normal bone marrow cells and
Autor:
Tilly W. Hulscher, Ronney A. De Abreu, Chris H. M. M. de Bruijn, Marinka A.H. Bakker, Jos P.M. Bökkerink, E. D. A. M. Schretlen, John M. van Baal
Publikováno v:
Biochemical pharmacology. 37(12)
MOLT-4 (T−), RAJI (B−), and KM-3 (non-B-non-T-, common ALL) malignant lymphoblasts demonstrated significant differences in their activities of purine de novo synthesis (PDNS) and purine salvage pathway and in their cell-kinetic parameters. Incuba
Autor:
Tilly W. Hulscher, John M. van Baal, Ronney A. De Abreu, Marinka A.H. Bakker, Jos P.M. Bökkerink
Publikováno v:
The Role of Pharmacology in Pediatric Oncology ISBN: 9789401083959
Methotrexate (MTX) and 6-mercaptopurine (6-MP) are widely used in the maintenance treatment of acute lymphoblastic leukemia (ALL) in children. Based on their biochemical interactions there are reasons to support a combination therapy of both drugs. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::766cbf6b7e4a44e2ae75ffd0ae60a320
https://doi.org/10.1007/978-94-009-4267-7_14
https://doi.org/10.1007/978-94-009-4267-7_14
Autor:
Ronney A. De Abreu, Gerard A. M. de Vaan, Jos P.M. Bökkerink, Tilly W. Hulscher, Marinka A.H. Bakker, John M. van Baal
Publikováno v:
Biochemical pharmacology. 35(20)
The effects of methotrexate (MTX) on cytotoxicity (trypan blue exclusion and soft agar clonal growth), cell cycle perturbation, and purine and pyrimidine ribonucleotide and deoxyribonucleotide pools have been studied in MOLT-4 malignant T-lymphoblast
Autor:
Jos P.M. Bökkerink, Tilly W. Hulscher, John M. van Baal, E. D. A. M. Schretlen, Ronney A. De Abreu, Chris H.M.M. De Bruyn, Marinka A.H. Bakker
Publikováno v:
Pediatric Research. 19:752-752
INFLUENCE OF METHOTREXATE ON PURINE AND PYRIMIDINI POOLS AND ON CELL PHASE DISTRIBUTION OF CULTURED HUMAN LYMPHOBLASTS: 50
Autor:
Tilly W. Hulscher, Jos P.M. Bökkerink, Gerard A. M. de Vaan, Ronney A. De Abreu, Marinka A.H. Bakker, E. D. A. M. Schretlen, Chris H.M.M. De Bruyn
Publikováno v:
Pediatric Research. 19:752-752
In this study we have examined the inhibition of purine de novo synthesis by methotrexate (MTX), with concommitant increase of intracellular PRPP concentrations and enhancement of 6-mercaptopurine (6MP) incorporation. We found a significant elevation